Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.645 USD | -1.67% | -3.28% | -35.21% |
13/05 | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
10/05 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.21% | 36Cr | |
+69.55% | 6.29TCr | |
-0.77% | 4.14TCr | |
+45.66% | 4.04TCr | |
-10.72% | 2.76TCr | |
+14.16% | 2.65TCr | |
-22.50% | 1.89TCr | |
+4.78% | 1.27TCr | |
+23.73% | 1.23TCr | |
+28.05% | 1.21TCr |
- Stock Market
- Equities
- ORGO Stock
- News Organogenesis Holdings Inc.
- Transcript : Organogenesis Holdings Inc., Q2 2022 Earnings Call, Aug 09, 2022